April 10th, 2021In the last decade, researchers have come to realize that tumors harbor bits of extrachromosomal DNA that can drive malignancy. Paul Mischel Apr 1, 2021 338 In the spring of 2012, my colleagues and I began to notice something strange in tumor...

April 10th, 2021The purpose of this study is to learn whether combining lenvatinib and pembrolizumab is a safe and effective treatment for patients with metastatic soft tissue sarcomas that cannot be surgically removed. This study will include patients with...

April 5th, 2021A team of researchers say they’ve designed a personalized cancer vaccine capable of inducing an immune response that fights off melanoma, the deadliest form of skin cancer, that lasts for several years. In a study published in the journal Nature...

April 5th, 2021It's Spring, Passover is ending, it's Easter Sunday..... their is a light at the end of the dark tunnel of the pandemic and hope for a new beginning. With the knowledge of new medications and technologies for early diagnosis of Chondrosarcoma, my...

April 3rd, 2021

April 1st, 2021On Saturday, March 20, 2021; the Chondrosarcoma CS Foundation, Inc. hosted its Second International Virtual Dialogue featuring two prominent world renown experts who introduced new techniques and innovations on how to diagnose and treat...

March 6th, 2021Two weeks from today the Chondrosarcoma Foundation will host the Second International Virtual Dialogue. It is scheduled for Saturday, March 20, 2021 from 1:00pm - 2:30pm (EST/ New York time) on Zoom. If you have not already, please register at...

March 1st, 2021The Virtual Dialogue is scheduled for Saturday, March 20 at 1:00pm (Eastern Standard Time / New York). Registration for the Virtual Dialogue is still open but we are excited to share that as of today, we have 70 registrations from 10 different...